Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
Crossref DOI link: https://doi.org/10.1007/s40262-021-01055-5
Published Online: 2021-07-03
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ogasawara, Ken http://orcid.org/0000-0002-4264-8927
Dodds, Michael
Mack, Timothy
Lymp, James
Dell’Aringa, Justine
Smith, Jeff
Text and Data Mining valid from 2021-07-03
Version of Record valid from 2021-07-03
Article History
First Online: 3 July 2021